Blog

Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy

Johanna Joyce/X

Nov 15, 2024, 21:26

Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy

Johanna Joyce, Professor at the University of Lausanne and Full Member of the international Ludwig Institute for Cancer Research, shared a post on X:

“A stimulating afternoon of scientific discovery translated into meaningful responses for cancer patients – an inspiring end to our Tumor Immunology & Immunotherapy Lab Links meeting!

Many thanks to Cathy Wu for the closing keynote, and all our incredible Lausanne speakers.”

Johanna Joyce is a Professor at the University of Lausanne, Switzerland, and Full Member of the international Ludwig Institute for Cancer Research. Prior to relocating her lab to Switzerland in 2016, she was a Full Member at Memorial Sloan Kettering Cancer Center and a Full Professor at Weill Cornell Medical School in New York. Johanna has been recognized for her contributions to cancer research through a series of awards including the Robert Bing Prize, Cloetta Prize, Metastasis Research Society Innovation Award, Swiss Bridge Award, American Cancer Society Scholar Award, Rita Allen Foundation Award, V Foundation Award, Sidney Kimmel Foundation Award, Fidler Innovation in Research Award, among many others. In 2017, she was elected as a Member of EMBO and a Fellow of the European Academy of Cancer Sciences, and in 2020 she was elected to the Women in Cancer Research Council of the AACR. Johanna currently serves on the advisory boards of the CRUK Cambridge Institute and Cancer Center, Cambridge, UK; the IRB Institute, Barcelona, Spain; the Robert Bosch Center for Tumor Diseases, Stuttgart, Germany; the Institute for Research in Biomedicine, Bellinzona, Switzerland; and on the editorial boards of Science, Cancer Cell, Cancer Discovery, The Journal of Experimental Medicine, and Trends in Cancer.